Global Asparaginase Market By Type (Escherichia Coli, Erwinia Chrysanthemi, And Pegylated), By Application (Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, And Other), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2030
- Published date: May 2022
- Report ID: 12058
- Number of Pages: 328
- Format:
- keyboard_arrow_up
Market.US announces publication of its most recently generated research report titled, “ Global Asparaginase Market by Source (Escherichia ColiErwinia, Chrysanthemi, Pegylated), By Application (Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Other Applications), and by Region – Global Forecast to 2030”, which offers a holistic view of the global Asparaginase Market through systematic segmentation that covers every aspect of the target market.
The global Asparaginase Market is projected to be US$ 389.2 Mn in 2020 to reach US$ 520.2 Mn by 2030 at a CAGR of 3.0%.
Asparaginase is an enzyme separated from different types of bacteria such as Erwinia chrysanthemi and Escherichia coli. During hydrolysis of l-asparagine, these enzymes act as a catalyst to form ammonia and aspartic acid as a byproduct. Asparagine has application in the food industry and medicine manufacturing. Three types of asparaginase present in the market are E. coli-asparaginase, Erwinia-asparaginase, and PEG-asparaginase.
Asparaginase is widely used in pharmaceuticals for treating cancer patients. The asparaginase catalyzes asparagine in the cells to produce aspartate and ammonia, causing cancer cells’ death. Administration of asparaginase is done subcutaneous, intramuscular, or intravenously.
trending_up Total Revenue in 2018$ 389.2 Mn
trending_up Market CAGR of the Next Ten Years3.0%
no_encryption Market Value (US$ Mn), Share (%) and Growth Rate (%) Comparison 2012-2028Purchase this report or a membership to unlock the market value (US$ Mn), share (%) and growth rate (%) comparison for this industry.- By Type
- By Region
- By Application
no_encryption Leading Companies Financial HighlightsPurchase this report or a membership to unlock the leading companies financial highlights for this industry.trending_up Market Revenue of the Next Ten Years$ 520.2 Mn
Acrylamide is carcinogenic in nature, which can be found in root vegetables, biscuits, cakes, and other food products. Allergies, neurological, pancreatitis, problems such as confusion occur among patients due to the repeated use of L-ASP for cancer treatment. New methods such as encapsulation of asparaginase are also expected to increase their efficiency.
Segmentation for Global Asparaginase Market, based on Source, Application, and Regions:
Based on Source:
- Escherichia Coli
- Erwinia Chrysanthemi
- Pegylated
Based on Application:
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Other Applications
Based on Regions:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Based on Major Companies
- Guangzhou Pharmaceutical Holdings Limited
- Kyowa Kirin Co.Ltd.
- Jazz Pharmaceuticals Plc
- Novozymes A/S
- Medac GmbH
- Changzhou Qianhong Bio-Pharma Co. Ltd.
- Taj Pharma
- United Biotech
- BioVendor Group
- JSN Chemicals Ltd.
Global Asparaginase Market Revenue (US$ Mn), 2020–2030
Asparaginase helps combat diseases such as cancer by inhibiting cancer growth, causing cells in the human body. L-asparagine present in leukemic cells is hydrolyzed by asparaginase into L-aspartic acid inhibiting protein synthesis and arresting cancer cells’ growth. The use of asparaginase in cancer treatment acts as the main factor that is expected to propel the growth of the target market. Asparagine is added in small amounts to the food before cooking to reduce the amino acid asparagine present in the food. The use of asparaginase in food processing also acts as a factor that is expected to propel the asparaginase market’s growth.
The ongoing global pandemic Covid-19 has affected the supply chain of pharmaceutical companies all over the world. This infused a vast gap between supply and demand, making it difficult for manufacturers and distributors to manage medicines’ supply. Also, side-effects associated with the use of asparaginase involves hypersensitive reaction such as allergies, bleeding, strokes, bone marrow suppression, pancreatitis, neurological problems such as seizure, confusion, and others. These factors are expected to hamper the market growth to a certain extent.
Global Asparaginase Market Attractiveness Analysis by Source, 2021–2030
The research report on the global Asparaginase Market includes profiles of some of the major companies such as Guangzhou Pharmaceutical Holdings Limited, Kyowa Kirin Co., Ltd., Jazz Pharmaceuticals Plc, Novozymes A/S, Medac GmbH, Changzhou Qianhong Bio-Pharma Co. Ltd., Taj Pharma, United Biotech, JSN Chemicals Ltd.etc.
For the Global Asparaginase Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
- Guangzhou Pharmaceutical Holdings Limited
- Kyowa Kirin Co.Ltd.
- Jazz Pharmaceuticals Plc
- Novozymes A/S
- Medac GmbH
- Changzhou Qianhong Bio-Pharma Co. Ltd.
- Taj Pharmaceuticals Company Profile
- United Biotech
- BioVendor Group
- JSN Chemicals Ltd.
- settingsSettings
Our Clients
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |